Genetic variation in the chromosome 17q23 amplicon and breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 6, 2009, Pages 1864-1868

  Kelemen, Linda E ^a   Wang, Xianshu ^b   Fredericksen, Zachary S ^b   Pankratz, V Shane ^b   Pharoah, Paul D P ^c   Ahmed, Shahana ^c   Dunning, Alison M ^c   Easton, Douglas F ^c   Vierkant, Robert A ^b   Cerhan, James R ^b   Goode, Ellen L ^b   Olson, Janet E ^b   Couch, Fergus J ^b  

^a Division of Population Health and Information   (Canada)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CHROMOSOME 17Q; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PPM1E GENE; PRIORITY JOURNAL; PRKCA GENE; SEPT4 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TBX2 GENE; TEX14 GENE; TLK2 GENE; TUBD1 GENE; TUMOR GENE; YPEL2 GENE;

ADULT; AGED; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE AMPLIFICATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 67449100029     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0486     Document Type: Article

References (34)

1. Knuutila S, Bjorkqvist AM, Autio K, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998;152:1107-1123 (Pubitemid 28221862)
2. Aulmann S, Adler N, Rom J, et al. c-myc amplifications in primary breast carcinomas and their local recurrences. J Clin Pathol 2006;59:424-428
3. Easton DF, Pooley KA, Dunning AM, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447:1087-1093 (Pubitemid 47014426)
4. Ewart-Toland A, Dai Q, Gao YT, et al. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis 2005;26:1368-1373 (Pubitemid 41417879)
5. Penault-Llorca F, Bertucci F, Adelaide J, et al. Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 1995;61:170-176
6. Heiskanen M, Kononen J, Barlund M, et al. CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors. Anal Cell Pathol 2001;22:229-234 (Pubitemid 32960014)
7. Tanaka T, Kimura M, Matsunaga K, Fukada D, Mori H, Okanao Y. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res 1999;59:2041-2044 (Pubitemid 29217660)
8. Kallioniemi A, Kallioniemi OP, Piper J, et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A 1994;91:2156-2160 (Pubitemid 24092062)
9. Tirkkonen M, Johannsson O, Agnarsson BA, et al. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res 1997;57:1222-1227 (Pubitemid 27152540)
10. Kuukasjarvi T, Karhu R, Tanner M, et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997;57:1597-1604 (Pubitemid 27175581)
11. Wu G, Sinclair C, Hinson S, Ingle JN, Roche PC, Couch FJ. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors. Cancer Res 2001;61:4951-4955 (Pubitemid 32681516)
12. Monni O, Barlund M, Mousses S, et al. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci U S A 2001;98:5711-5716 (Pubitemid 32435707)
13. Jacobs JJ, Keblusek P, Robanus-Maandag E, et al. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet 2000;26:291-299 (Pubitemid 30824608)
14. Paavola P, Horelli-Kuitunen N, Palotie A, Peltonen L. Characterization of a novel gene, PNUTL2, on human chromosome 17q22-q23 and its exclusion as the Meckel syndrome gene. Genomics 1999;55:122-125 (Pubitemid 29058903)
15. Koh CG, Tan EJ, Manser E, Lim L. The p21-activated kinase PAK is negatively regulated by POPX1 and POPX2, a pair of serine/threonine phosphatases of the PP2C family. Curr Biol 2002;12:317-321 (Pubitemid 34161477)
16. Morse-Gaudio M, Connolly JM, Rose DP. Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype. Int J Oncol 1998;12:1349-1354 (Pubitemid 28239948)
17. Ways DK, Kukoly CA, deVente J, et al. MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 1995;95:1906-1915
18. Carrera P, Moshkin YM, Gronke S, et al. Tousled-like kinase functions with the chromatin assembly pathway regulating nuclear divisions. Genes Dev 2003;17:2578-2590 (Pubitemid 37271427)
19. Greenbaum MP, Ma L, Matzuk MM. Conversion of midbodies into germ cell intercellular bridges. Dev Biol 2007;305:389-396 (Pubitemid 46686608)
20. Glotzer M. The molecular requirements for cytokinesis. Science 2005;307:1735-1739 (Pubitemid 40388608)
21. Sinclair CS, Adem C, Naderi A, et al. TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors. Cancer Res 2002;62:3587-3591 (Pubitemid 34728829)
22. Wang X, Zhou YX, Qiao W, et al. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 2006;25:7148-7158 (Pubitemid 44764184)
23. Finetti P, Cervera N, Charafe-Jauffret E, et al. Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis. Cancer Res 2008;68:767-776 (Pubitemid 351206753)
24. Wang X, Goode EL, Fredericksen ZS, et al. Association of genetic variation in genes implicated in the β-catenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2008;17:2101-2108
25. Steemers FJ, Gunderson KL. Illumina, Inc. Pharmacogenomics 2005;6:777-782
26. Oliphant A, Barker DL, Stuelpnagel JR, Chee MS. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques 2002;Suppl: 56-8:60-61
27. Fan JB, Oliphant A, Shen R, et al. Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol 2003;68:69-78. (Pubitemid 38955554)
28. Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-874 (Pubitemid 47014500)
29. Pharoah PD, Tyrer J, Dunning AM, et al. Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 2007;3:e42. (Pubitemid 46535758)
30. Westfall PH, Young SS. Resampling-based multiple testing. New York: John Wiley and Sons, Inc.; 1993. p. 66-67
31. Garcia-Closas M, Hall P, Nevanlinna H, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 2008;4:e1000054. (Pubitemid 351656691)
32. Chanock SJ, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature 2007;447:655-660 (Pubitemid 46889722)
33. Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE. Circulating 2-hydroxy- and 16α-hydroxy estrone levels and risk of breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008;17:2029-2035
34. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-46